In conclusion, our study provides compelling evidence, both in vitro and in vivo, for the crucial role of METTL3, a core component of the m6A methyltransferase complex, in mediating OXA resistance in HCC. This evidence concerns the gene METTL3 and hepatocellular carcinoma.